1. Introduction
Episodes of emergency and re-emergence of arthropod-borne viruses (arboviruses) are associated with the increasing contact among viruses, vectors, and human hosts [
1]. This context is supported by factors such as globalization, anthropogenic changes in biomes, climate change, geographic spread of potential disease vectors, and unsanitary conditions in urban areas [
2,
3]. As a result, the high density of the vector population, the presence of susceptible hosts, and favorable environmental conditions result on the successful circulation, maintenance, and dissemination of multiple arboviruses in the environment [
1,
2,
3]. In Brazil, the cocirculation of Dengue (DENV), Zika (ZIKV), and Chikungunya (CHIKV) viruses culminated in the triple epidemic registered in 2015-2016 [
4]. Since then, these three viruses are found in urban areas, having humans as vertebrate hosts and
Aedes aegypti as the main mosquito vector [
5]. The cocirculation of arboviruses is influenced by similar biological, ecological, and socioeconomic factors, leading to an epidemiological synergy of seasonality and occurrence rates [
2,
6,
7,
8]. Recently, Mayaro virus (MAYV), an endemic arbovirus widely found in Central America and the Amazon region, has drawn attention due to its ability to invade urban areas and cause outbreaks [
9,
10,
11], with cases reported in the North, Midwest, Southeast, and Northeast regions of Brazil [
12].
One of the main factors for an arbovirus, such as MAYV, to establish itself in an urban environment is the presence of competent mosquito species for the virus [
13,
14,
15]. In the sylvatic cycle, MAYV has non-human primates and other mammals as vertebrate hosts and
Haemagoggus spp. mosquitoes as vectors [
9,
11]. On the other hand, entomological surveillance studies conducted in the country have detected
Ae. aegypti naturally infected with MAYV in the Brazilian states of Mato Grosso [
16] and Goiás [
17]. Thus, the regular notification of MAYV cases near the main tropical cities,
Ae. aegypti as a main urban vector, and the presence of susceptible human hosts result in a higher potential for establishing MAYV in an urban cycle [
18].
From the standpoint of the vector biology, it is important to understand the dynamics between different viruses in the same individual mosquito. This phenomenon includes the coinfection (simultaneous infection of the mosquito by the viruses in a single blood meal) and superinfection (sequential infection of the mosquito by the viruses, involving more than one blood meal) mechanisms [
19,
20]. Both coinfection and superinfection can result in different scenarios: virus amplification; virus inhibition; competition between viruses; and neutrality [
2,
21]. In nature, superinfection is more likely to occur when compared to coinfection, as the mosquito becomes infected sequentially by performing a blood meal on several viremic hosts instead of a single meal on a coinfected viremic host [
2,
22,
23]. Also, superinfection is commonly related to viral interference, referring to the inability of a virus to replicate in an organism or cell that is previously infected by another virus [
24,
25], which was already demonstrated between Yellow Fever virus (YFV) and DENV-2 [
26], MAYV and ZIKV [
21], and CHIKV and MAYV [
22].
Therefore, in a setting of arboviruses cocirculation in Brazil and a high density of Ae. aegypti mosquitoes, we investigated how coinfection and superinfection impact the virus dynamics between two alphaviruses of a high epidemiological importance, CHIKV and MAYV, using an Ae. aegypti colony. The study consisted of blood-meal experiments, drawing different methods for coinfection and superinfection assays, and comparative analyses for the consequent scenarios.
4. Discussion
The current epidemiological landscape on a global scale has been characterized by numerous cases of arbovirus (re)emergence, accompanied by their rapid geographical dissemination [
1]. This phenomenon has prompted the simultaneous circulation of diverse pathogens within particular regions [
34]. In Brazil, alongside DENV, ZIKV, CHIKV, and YFV, Oropouche virus (OROV) has recently emerged as an increasingly notified virus, surpassing four thousand cases [
35]. In this context, considering the potential emergence of MAYV in urban regions of Brazil, a country with the highest reported cases of MAYV human infections [
9,
10,
11,
12,
18], and the favorable conditions for the simultaneous circulation of arboviruses- including the presence of competent vectors and susceptible vertebrate hosts [
5]- it becomes imperative to comprehend the relationship among various viruses within the same vector [
22]. This area of investigation remains full of gaps in the scientific literature, underscoring its critical significance [
21]. Confronted with this scenario, we investigated the coinfection and superinfection consequences on the replication of CHIKV and MAYV in
Ae. aegypti mosquitoes.
In coinfection scenarios, both CHIKV and MAYV replicate similarly to single infections, indicating minimal interference in the transmissibility of the viruses and, consequently, in vector competence. Previous studies of vector competence involving
Ae. aegypti have shown this mosquito has the ability to become infected and transmit multiple viruses during a single blood meal, such as combinations of DENV, ZIKV, and CHIKV [
36,
37], ZIKV-MAYV [
21], and, as observed in this study, CHIKV-MAYV [
22], supporting the hypothesis that coinfection event does not significantly interfere with the amplification of the viruses [
2,
37,
38]. On the other hand, we noted interference in the transmission of the viruses during the second blood meal in the superinfection experiments by CHIKV and MAYV. This shows the occurrence of a potential inhibition of viral replication. The group superinfected with CHIKV displayed a predominance of MAYV (first blood meal), as only MAYV was detected in saliva collected from the 7th dpe. Conversely, the group superinfected with MAYV displayed a prevalence of CHIKV (first blood meal), as supported by TR results in which only CHIKV was detected in samples collected on the 13th dpe. Previous studies have also found similar results. Kantor et al. [
22] found interference in the transmission between MAYV and CHIKV in
Ae. aegypti mosquitoes superinfected by CHIKV, similar to our findings. However, they did not find interference in the reverse scenario (mosquitoes superinfected by MAYV). In contrast, our study identified interference in mosquitoes superinfected by MAYV as well. Additionally, Abrao & Da Fonseca [
26] reported, through in vitro superinfection studies, a reduced viral replication of Yellow Fever virus (YFV) in C6/36 cells previously infected with DENV-2 when compared to single infections by YFV [
26].
Previous studies have discussed factors that may be associated with interference, inhibition, or even exclusion of viral replication in a superinfection scenario [
26]. One key factor is the activation of the vector host's immune system by the primary viral infection, which can make it difficult for a subsequently acquired arbovirus to replicate [
2,
26]. Additionally, other factors could be involved, such as the vector's microbiome competition, a decrease in cellular resources required for the replication of the secondarily acquired virus, reduced binding of the virion to cell surface receptors during the second infection, and inhibition of the nucleocapsid uncoating related to the second infection [
25,
39,
40]. However, this phenomenon remains somewhat ambiguous, as certain studies have indicated no interference in cases of superinfection. For instance, Kuwata et al. [
41] demonstrated in vitro that a pre-existing infection with CxFV (an insect-specific flavivirus initially isolated from
Culex spp.) did not interfere with Japanese Encephalitis virus (JEV) or DENV infection at the cellular (CTR cells) level. Similarly, Kent et al. [
42] reported that prior exposure to CxFV had no noticeable effect on West Nile virus (WNV) replication in experiments conducted with C6/36 cells.
The potential for viral interference in superinfection scenarios has been extensively investigated, particularly in the context of insect-specific viruses (ISVs) [
24]. These viruses can replicate exclusively in insect cells and can directly impact the infection, dissemination, and transmission of arboviruses, as demonstrated between Nhumirim virus (NHUV) and WNV in
Culex quinquefasciatus [
43]
, and Eilat virus (EILV) and CHIKV in
Ae. aegypti [
40]. These studies support the exploration of innovative methods for vector control [
22,
24,
39,
41]. From a different perspective, viral interference between mammalian pathogenic arboviruses may, to some extent, provide explanations for the infrequent or nonexistent occurrence of certain viruses in regions with a high prevalence of others [
24,
26]. Abrao & Da Fonseca [
26] previously proposed this concept to account for the limited occurrence of YFV in areas with substantial DENV circulation. However, this hypothesis remains speculative, as it requires not only in vitro analyses but also in vivo and field validations for confirmation. Regarding our results, we observed interference in both pathways MAYV-superinfection and CHIKV-superinfection, which allows us to discuss a possible variable that contributes to the absence of MAYV emergence in Brazilian urban areas, characterized by a high circulation of CHIKV and a high density of
Ae. aegypti [
5], which, in turn, demonstrated to be competent for MAYV [
15,
44]. Similarly, the interference caused by an initial MAYV infection in mosquitoes might contribute to the comparatively low detection rates of CHIKV in the northern regions of Brazil [
45]. This phenomenon is compounded by the fact that CHIKV has already adapted to urban environments, undergoing direct amplification cycles in humans [
46], and only emerged in Brazil in 2014 [
47], whereas MAYV has been circulating in the northern region since the 20th century [
48].
It is important to note potential biases associated with the forced salivation technique, used in the present study, such as its non-standardization, even though it is considered the gold method for assessing transmission rates in vector competence studies without resorting to an animal model, and the non-quantification of saliva expulsion [
49]. Given this context, it is crucial to conduct vector competence studies using animal models. Such studies should observe histopathologic effects and quantify viral presence in various tissues, as exemplified by Krokovsky et al. [
15]. In our study, we observed low numbers of infected saliva across all tested groups, which implies the existence of a robust barrier within the mosquito's salivary gland against CHIKV and MAYV, despite a viral infection disseminated in the organism [
38,
50,
51]. Low TR have also been observed in prior studies involving CHIKV and MAYV within
Ae. aegypti. For instance, Göertz et al. [
38] reported a TR of 21.2% at 14 dpe for mosquitoes single infected by CHIKV, using initial titers with log 10
7 TCID50/ml. In the same study, the TR was 14.6% for CHIKV in mosquitoes coinfected with ZIKV (72.9%), with an initial titer of log 10
7 TCID50/ml for both viruses [
38]. Another study by Wiggins et al. [
52] found TR of 10% and 23% at 6 and 12 dpe, respectively, for mosquitoes single infected by MAYV, using an initial viral titer with a log of 10
10 PFU/ml.
Our findings indicate that in a coinfection scenario, both MAYV and CHIKV can replicate in Ae. aegypti without adversely affecting viral replication and, consequently, vector competence for both viruses. However, superinfection events by MAYV or CHIKV can disrupt the transmission of the secondary acquired virus. This highlights a notable epidemiological concern, particularly in Brazilian urban areas where multiple viruses, including DENV, ZIKV, CHIKV, YFV, and OROV, circulate, underscoring the critical importance of multiplex diagnostic methods for simultaneous detection of these co-circulating viruses. Therefore, these results bear significant consequences for shaping public health strategies in the region, emphasizing the intricate nature of arbovirus transmission scenarios and the related epidemiological risks.
Figure 1.
Groups of mosquitoes analyzed in the single infection, coinfection and superinfection experiments: (A) Single infection with MAYV or CHIKV. (B) Coinfection with MAYV and CHIKV. (C) Superinfection with CHIKV. (D) Superinfection with MAYV.
Figure 1.
Groups of mosquitoes analyzed in the single infection, coinfection and superinfection experiments: (A) Single infection with MAYV or CHIKV. (B) Coinfection with MAYV and CHIKV. (C) Superinfection with CHIKV. (D) Superinfection with MAYV.
Figure 2.
Infection and Dissemination rates (%) for MAYV and number of MAYV RNA copies/ml in the single infection and coinfection assays. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for MAYV single-infected group and n=30 for MAYV and CHIKV coinfected group.
Figure 2.
Infection and Dissemination rates (%) for MAYV and number of MAYV RNA copies/ml in the single infection and coinfection assays. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for MAYV single-infected group and n=30 for MAYV and CHIKV coinfected group.
Figure 3.
Infection and Dissemination rates (%) for CHIKV and number of CHIKV RNA copies/ml in the single infection and coinfection assays. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for CHIKV single-infected group and n=30 for MAYV and CHIKV coinfected group.
Figure 3.
Infection and Dissemination rates (%) for CHIKV and number of CHIKV RNA copies/ml in the single infection and coinfection assays. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for CHIKV single-infected group and n=30 for MAYV and CHIKV coinfected group.
Figure 4.
Transmission rate (%) for MAYV and CHIKV and number of MAYV and CHIKV RNA copies/ml in the coinfection assay. (A) Transmission rate (TR) for MAYV; (B) MAYV RNA copy number/ml in positive saliva; (C) Transmission rate (TR) for CHIKV; (D) CHIKV RNA copy number/ml in positive saliva. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 saliva for MAYV and CHIKV single-infected groups and n=30 for MAYV and CHIKV coinfected group.
Figure 4.
Transmission rate (%) for MAYV and CHIKV and number of MAYV and CHIKV RNA copies/ml in the coinfection assay. (A) Transmission rate (TR) for MAYV; (B) MAYV RNA copy number/ml in positive saliva; (C) Transmission rate (TR) for CHIKV; (D) CHIKV RNA copy number/ml in positive saliva. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 saliva for MAYV and CHIKV single-infected groups and n=30 for MAYV and CHIKV coinfected group.
Figure 5.
Infection and Dissemination rates (%) for MAYV and number of MAYV RNA copies/ml in the superinfection assay. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for MAYV single-infected group and n=30 for MAYV or CHIKV superinfected groups.
Figure 5.
Infection and Dissemination rates (%) for MAYV and number of MAYV RNA copies/ml in the superinfection assay. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for MAYV single-infected group and n=30 for MAYV or CHIKV superinfected groups.
Figure 6.
Infection and Dissemination rates (%) for CHIKV and number of CHIKV RNA copies/ml in the superinfection assay. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for CHIKV single-infected group and n=30 for MAYV or CHIKV superinfected groups.
Figure 6.
Infection and Dissemination rates (%) for CHIKV and number of CHIKV RNA copies/ml in the superinfection assay. (A) Infection rate (IR); (B) Viral RNA copy number/ml in positive midguts; (C) Dissemination rate (DR); (D) Viral RNA copy number/ml in positive carcasses. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 samples of each tissue (midgut and carcass) for CHIKV single-infected group and n=30 for MAYV or CHIKV superinfected groups.
Figure 7.
Transmission rate (%) for MAYV and CHIKV and number of MAYV and CHIKV RNA copies/ml in the superinfection assay. (A) Transmission rate (TR) for MAYV; (B) MAYV RNA copy number/ml in positive saliva; (C) Transmission rate (TR) for CHIKV; (D) CHIKV RNA copy number/ml in positive saliva. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 saliva for MAYV and CHIKV single-infected groups and n=30 for MAYV or CHIKV superinfected groups.
Figure 7.
Transmission rate (%) for MAYV and CHIKV and number of MAYV and CHIKV RNA copies/ml in the superinfection assay. (A) Transmission rate (TR) for MAYV; (B) MAYV RNA copy number/ml in positive saliva; (C) Transmission rate (TR) for CHIKV; (D) CHIKV RNA copy number/ml in positive saliva. Dpe- days post-exposure; * p ≤ 0,05, ** p ≤ 0,01, *** p ≤ 0,001, **** p ≤ 0,0001, ns - non-significant. It was analyzed n=10 saliva for MAYV and CHIKV single-infected groups and n=30 for MAYV or CHIKV superinfected groups.
Table 1.
Average initial viral titer, measured in Plaque Forming Units (PFU), for MAYV and CHIKV used on the single infection, coinfection and superinfection assays.
Table 1.
Average initial viral titer, measured in Plaque Forming Units (PFU), for MAYV and CHIKV used on the single infection, coinfection and superinfection assays.
Group |
Virus |
1st blood-meal |
2nd blood-meal |
Single infection- MAYV |
MAYV |
5,5 x 107
|
-* |
Single infection- CHIKV |
CHIKV |
3,1 x 107
|
-* |
Coinfection MAYV + CHIKV |
MAYV |
5,5 x 107
|
-* |
|
CHIKV |
3,1 x 107
|
-* |
Superinfection by MAYV |
CHIKV |
1,4 x 107
|
- |
|
MAYV |
- |
3,1 x 107
|
Superinfection by CHIKV |
MAYV |
3,5 x 107
|
- |
|
CHIKV |
- |
8,5 x 106
|